TickerFacts.

A business in context

BIOA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-02 · 0001193125-26-412300 · Items 8.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-335407

  3. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-335368 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-06-29 · 0001836297-26-000005

  5. 4 · Ownership change

    Report date 2026-06-10 · 0001840663-26-000002

  6. 4 · Ownership change

    Report date 2026-06-10 · 0001771213-26-000004

  7. 4 · Ownership change

    Report date 2026-06-10 · 0001573785-26-000003

  8. 4 · Ownership change

    Report date 2026-06-10 · 0001253886-26-000006

  9. 4 · Ownership change

    Report date 2026-06-10 · 0001245624-26-000002

  10. 8-K · Current report

    Report date 2026-06-10 · 0001193125-26-268518 · Items 5.07

  11. 4 · Ownership change

    Report date 2026-06-10 · 0001184175-26-000002

  12. 8-K · Current report

    Report date 2026-05-08 · 0001193125-26-213472 · Items 2.02,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-213466

  14. 4 · Ownership change

    Report date 2026-04-23 · 0001120478-26-000013

  15. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001193125-26-166738

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-120873

  17. 8-K · Current report

    Report date 2026-03-24 · 0001193125-26-120864 · Items 2.02,7.01,9.01

  18. 8-K · Current report

    Report date 2026-01-21 · 0001193125-26-019536 · Items 1.01,7.01,9.01

  19. 8-K · Current report

    Report date 2026-01-20 · 0001193125-26-016046 · Items 7.01,8.01,9.01

  20. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-009911 · Items 7.01,8.01,9.01

  21. 8-K · Current report

    Report date 2025-12-04 · 0001193125-25-307541 · Items 7.01,8.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-270012

  23. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269986 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104176

  25. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-104151 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-06-05 · 0000950170-25-083746 · Items 5.07

  27. 8-K · Current report

    Report date 2025-06-04 · 0000950170-25-081409 · Items 8.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-064552

  29. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-064547 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0000950170-25-055371

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-042759

  32. 8-K · Current report

    Report date 2025-03-20 · 0000950170-25-042747 · Items 2.02,9.01

  33. SC 13G · Ownership disclosure

    0001193125-24-258589

  34. SC 13G · Ownership disclosure

    0001104659-24-116796

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-123445

  36. 8-K · Current report

    Report date 2024-11-07 · 0000950170-24-123437 · Items 2.02,9.01

  37. SC 13G · Ownership disclosure

    0001104659-24-106678

  38. SC 13D · Ownership disclosure

    0001104659-24-106374

  39. SC 13D · Ownership disclosure

    0001104659-24-104494

  40. 8-K · Current report

    Report date 2024-09-25 · 0001193125-24-227949 · Items 1.01,3.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 2 transaction rows2SGrant / award: 0 transaction rows0AExercise / conversion: 16 transaction rows16MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

18 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock4000.08.39
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock4065.04.3
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock7861.04.38
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock20216.025.19
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock4290.010.85
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
7861.00.0
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
4290.00.0
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
4000.00.0
2026-06-30
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
4065.00.0
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock7261.08.39
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock8958.04.3
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock14198.04.38
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock42350.025.21
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock9301.010.85
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
9301.00.0
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
7261.00.0
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
8958.00.0
2026-06-29
2026-07-01
Barton Shane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
14198.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001709941BioAge Labs, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

    Explore the CPI history ↗